Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01GTC
|
|||
| Drug Name |
TAK-041
|
|||
| Indication | XY disorder of sex development due to androgen resistance [ICD-11: LD2A.4; ICD-10: E34.5] | Phase 1 | [1] | |
| Company |
Takeda Deerfield, IL
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | G-protein-coupled receptor PGR3 (GPR139) | Target Info | Agonist | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.